SEX-SPECIFIC BIOMARKERS FOR CARDIOVASCULAR DISEASES
EAS Academy. Nordestgaard B. 05/30/16; 136709 Topic: Risk factors
Disclosure(s): Conflict of Interest Disclosure: Consultancies or talks sponsored by AstraZeneca, Merck, Omthera, Sanofi, Regeneron, IONIS, Aegerion, Dezima, Fresenius, B Braun, Kaneka, Amgen, Denka Seiken, Kowa
Prof. Borge Nordestgaard
Prof. Borge Nordestgaard

Access to Premium Content is a benefit of Individual EAS membership. Apply for membership


Access EAS content "anytime, anywhere" with the EAS Academy App for iOS and Android


For any questions contact us at office@eas-society.org

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies